Wiley Bros. Aintree Capital, LLC United Therapeutics Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 625 shares of UTHR stock, worth $222,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
625Holding current value
$222,118% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
673Shares Held
42.2MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.57 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.13 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$795 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...